The global hydrophobic interaction chromatography market size was valued at USD 366.13 million in 2023, driven by heightened Demand for Monoclonal Antibodies. The market is estimated to grow at a CAGR of 6.9% during the forecast period 2024-2032 to attain a value of USD 667.48 million by 2032.
Based on sample type, the monoclonal antibodies segment is predicted to account for a significant market share in the hydrophobic interaction chromatography industry. The monoclonal antibodies are duplicated antibodies that are produced artificially through the process of genetic engineering.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The segment growth can be attributed to the increased demand for monoclonal antibodies in cancer treatment, bone marrow transplants, and other applications. In this regard, the hydrophobic interaction chromatography process is used increasingly to purify the monoclonal antibodies. These factors are predicted to aid the market growth in the coming years.
North America is estimated to possess a substantial share of the hydrophobic interaction chromatography industry in the forecast period. This growth can be attributed to the rising incidences of chronic illnesses in the region, which is expected to lead to a heightened demand for antibodies development. For instance, in the US, an estimated number of 1,806,590 cancer cases were reported in 2021. In addition, the rising investments in the funding of research for hydrophobic interaction chromatography are also anticipated to aid the market growth.
Hydrophobic interaction chromatography refers to the process of separating proteins based on their surface hydrophobicity. It is a popular method of chromatography, as it deploys a less denaturing environment, which helps keep the biological activity of the protein intact. This process also aids in removing impurities and aggregate species that may be present in a solution.
By product, the market is divided into:
On the basis of sample type, the industry can be segmented into:
Based on end user, the market can be categorised into:
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The growing capital expenditure in the pharmaceutical sector is driving the growth of the hydrophobic interaction chromatography industry. The growing geriatric population, which is more likely to contract severe ailments such as autoimmune diseases and others, is also supporting the market. In addition, the rising issues of cancer, such as breast and prostate cancer, are also expected to contribute to the industry growth in the coming years. Moreover, the technological advancements and the rising investments in research and development activities in the healthcare sector are anticipated to propel the market growth over the forecast period.
The report gives a detailed analysis of the following key players in the global hydrophobic interaction chromatography market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.
|Scope of the Report
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|Breakup by Product
|Breakup by Sample Type
|Breakup by Application
|Breakup by End User
|Breakup by Region
|Report Price and Purchase Option
|Explore our purchase options that are best suited to your resources and industry needs.
|Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Hydrophobic Interaction Chromatography Market Overview
3.1 Global Hydrophobic Interaction Chromatography Market Historical Value (2017-2023)
3.2 Global Hydrophobic Interaction Chromatography Market Forecast Value (2024-2032)
4 Global Hydrophobic Interaction Chromatography Market Landscape
4.1 Global Hydrophobic Interaction Chromatography Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Hydrophobic Interaction Chromatography Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Sample Type
4.2.3 Analysis by Application
4.2.4 Analysis by End User
5 Global Hydrophobic Interaction Chromatography Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Hydrophobic Interaction Chromatography Market Segmentation
6.1 Global Hydrophobic Interaction Chromatography Market by Product
6.1.1 Market Overview
6.2 Global Hydrophobic Interaction Chromatography Market by Sample Type
6.2.1 Market Overview
6.2.2 Monoclonal Antibodies
6.3 Global Hydrophobic Interaction Chromatography Market by Application
6.3.1 Market Overview
220.127.116.11 Glucose Monitoring
18.104.22.168 Cardiac Marker
22.214.171.124 Infectious Disease Detection
126.96.36.199 Coagulation Monitoring
188.8.131.52 Pregnancy Testing
184.108.40.206 Blood Gas and Electrolyte Detection
220.127.116.11 Detection of Tumor or Cancer Marker
18.104.22.168 Urinalysis Testing
22.214.171.124 Cholesterol Testing
6.3.3 Home Diagnostic
126.96.36.199 Glucose Monitoring
188.8.131.52 Pregnancy Testing
184.108.40.206 Cholesterol Testing
6.3.4 Research Labs
6.3.5 Environmental Monitoring
6.3.6 Food and Beverages
6.4 Global Hydrophobic Interaction Chromatography Market by End User
6.4.1 Market Overview
6.4.2 Home Healthcare Diagnostics
6.4.3 POC Testing
6.4.4 Food Industry
6.4.5 Research Laboratories
6.4.6 Security and Biodefence
6.5 Global Hydrophobic Interaction Chromatography Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Hydrophobic Interaction Chromatography Treatment Market
7.1 Market Share by Country
7.2 United States of America
8 Europe Hydrophobic Interaction Chromatography Treatment Market
8.1 Market Share by Country
8.2 United Kingdom
9 Asia Pacific Hydrophobic Interaction Chromatography Treatment Market
9.1 Market Share by Country
10 Latin America Hydrophobic Interaction Chromatography Treatment Market
10.1 Market Share by Country
11 Middle East and Africa Hydrophobic Interaction Chromatography Treatment Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.5 South Africa
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
17 Supplier Landscape
17.1 Bio-Rad Laboratories, Inc.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.2 GE Healthcare
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.3 Sartorius AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.4 Tosoh Bioscience GmbH
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.5 Sepax Technologies, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.6 Thermo Fisher Scientific Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.7 Cecil Instrumentation Services Ltd.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.8 Hitachi High-Tech America, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.9 Agilent Technologies, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.10 Restek Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.11 PerkinElmer Inc. (U.S.)
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.12 JASCO Corporation
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.13 Hitachi High-Tech America, Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.14 Tosoh Bioscience
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
18 Global Hydrophobic Interaction Chromatography Market - Distribution Model (Additional Insight)
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
*Additional insights provided are customisable as per client requirements.
It is estimated that the global market for hydrophobic interaction chromatography reached a value of USD 366.13 million in 2023.
The market is anticipated to grow at a CAGR 6.9% during the forecast period of 2024-2032 to reach a value of USD 667.48 million by 2032.
The major drivers of the industry, such as the increased demand for monoclonal antibodies, rising incidences of chronic illnesses, growing geriatric population, rapid technological advancements, and the rapid investments in the funding of research for hydrophobic interaction chromatography, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the heightened capital expenditure in the pharmaceutical sector.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant products considered within the market report include resins, columns, buffers, and others.
The significant sample types include monoclonal antibodies, vaccines, and others.
The major end users include pharmaceutical and biopharmaceutical companies, CROs and CMOs, research and academic institutes, and others.
The major players in the industry are Bio-Rad Laboratories, Inc., GE Healthcare, Sartorius AG, Tosoh Bioscience GmbH, Sepax Technologies, Inc., and others.
Single User License
Five User License
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.